{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T16:22:42Z","timestamp":1784132562451,"version":"3.55.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["2021YFH0169"],"award-info":[{"award-number":["2021YFH0169"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.xphs.2024.06.010","type":"journal-article","created":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T23:03:34Z","timestamp":1718751814000},"page":"2744-2755","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Targeting Inflammatory Lesions Facilitated by Galactosylation Modified Delivery System Eudragit\/Gal-PLGA@Honokiol for the treatment of Ulcerative Colitis"],"prefix":"10.1016","volume":"113","author":[{"given":"Anqi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wugui","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongtao","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinjia","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhoujiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Teng","family":"Vong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2024.06.010_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/9419085","article-title":"Anticolitic effect of berberine in rat experimental model: impact of PGE2\/p38 MAPK pathways","volume":"2020","author":"Jia","year":"2020","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.xphs.2024.06.010_bib0002","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.fct.2018.03.002","article-title":"Abdel Moneim AE. Ziziphus spina-christi fruit extract suppresses oxidative stress and p38 MAPK expression in ulcerative colitis in rats via induction of Nrf2 and HO-1 expression","volume":"115","author":"Almeer","year":"2018","journal-title":"Food Chem Toxicol"},{"issue":"37","key":"10.1016\/j.xphs.2024.06.010_bib0003","doi-asserted-by":"crossref","first-page":"55790","DOI":"10.1007\/s11356-022-19747-1","article-title":"Anticolitic activity of prodigiosin loaded with selenium nanoparticles on acetic acid\u2013induced colitis in rats","volume":"29","author":"Kassab","year":"2022","journal-title":"Environ Sci Pollut Res"},{"issue":"2","key":"10.1016\/j.xphs.2024.06.010_bib0004","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1053\/j.gastro.2016.10.020","article-title":"Understanding and preventing the global increase of inflammatory bowel disease","volume":"152","author":"Kaplan","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.xphs.2024.06.010_bib0005","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.actbio.2020.09.017","article-title":"Colitis-targeted hybrid nanoparticles-in-microparticles system for the treatment of ulcerative colitis","volume":"116","author":"Naeem","year":"2020","journal-title":"Acta Biomater"},{"issue":"11","key":"10.1016\/j.xphs.2024.06.010_bib0006","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1517\/17425247.2012.730517","article-title":"Oral colon-specific therapeutic approaches toward treatment of inflammatory bowel disease","volume":"9","author":"Bo Xiao","year":"2012","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.xphs.2024.06.010_bib0007","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ejphar.2019.02.021","article-title":"iTRAQ-based pharmacoproteomics reveals potential targets of berberine, a promising therapy for ulcerative colitis","volume":"850","author":"Li","year":"2019","journal-title":"Eur J Pharmacol"},{"issue":"11","key":"10.1016\/j.xphs.2024.06.010_bib0008","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1039\/c3tb21564d","article-title":"Glycoprotein CD98 as a receptor for colitis-targeted delivery of nanoparticles","volume":"2","author":"Xiao","year":"2014","journal-title":"J Mater Chem B"},{"issue":"2","key":"10.1016\/j.xphs.2024.06.010_bib0009","first-page":"81","article-title":"Progress in active compounds effective on ulcerative colitis from Chinese medicines","volume":"17","author":"Cao","year":"2019","journal-title":"Chin J Nat Med"},{"issue":"10401","key":"10.1016\/j.xphs.2024.06.010_bib0010","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(23)00966-2","article-title":"Peyrin-biroulet L. Ulcerative colitis","volume":"402","author":"Le Berre","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.xphs.2024.06.010_bib0011","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1146\/annurev-med-052919-120048","article-title":"New therapeutics for ulcerative colitis","volume":"72","author":"Hirten","year":"2021","journal-title":"Annu Rev Med"},{"issue":"1","key":"10.1016\/j.xphs.2024.06.010_bib0012","doi-asserted-by":"crossref","DOI":"10.1186\/s13020-020-0296-z","article-title":"Targeting NF-\u03baB pathway for treating ulcerative colitis: comprehensive regulatory characteristics of Chinese medicines","volume":"15","author":"Lu","year":"2020","journal-title":"Chin Med"},{"key":"10.1016\/j.xphs.2024.06.010_bib0013","article-title":"Traditional Chinese medicine prescription Shenling BaiZhu powder to treat ulcerative colitis: Clinical evidence and potential mechanisms","volume":"13","author":"Chen","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.xphs.2024.06.010_bib0014","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ijpharm.2018.12.074","article-title":"Advances in orally-delivered pH-sensitive nanocarrier systems; an optimistic approach for the treatment of inflammatory bowel disease","volume":"558","author":"Zeeshan","year":"2019","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.xphs.2024.06.010_bib0015","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.jfma.2020.09.002","article-title":"In vitro antimicrobial and antipro-inflammation potential of honokiol and magnolol against oral pathogens and macrophages","volume":"120","author":"Chiu","year":"2021","journal-title":"J Formos Med Assoc"},{"issue":"3","key":"10.1016\/j.xphs.2024.06.010_bib0016","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/01635581.2021.1931364","article-title":"Natural lignans honokiol and magnolol as potential anticarcinogenic and anticancer agents. A comprehensive mechanistic review","volume":"74","author":"Mottaghi","year":"2022","journal-title":"Nutr Cancer"},{"issue":"16","key":"10.1016\/j.xphs.2024.06.010_bib0017","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1055\/a-0642-1966","article-title":"Safety and toxicology of magnolol and honokiol","volume":"84","author":"Sarrica","year":"2018","journal-title":"Planta Med"},{"issue":"2","key":"10.1016\/j.xphs.2024.06.010_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192178","article-title":"Synthesis of magnolol and honokiol derivatives and their effect against hepatocarcinoma cells","volume":"13","author":"Maioli","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.xphs.2024.06.010_bib0019","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11010022","article-title":"Honokiol eliminates glioma\/glioblastoma stem cell-like cells via JAK-STAT3 signaling and inhibits tumor progression by targeting epidermal growth factor receptor","volume":"11","author":"Fan","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.xphs.2024.06.010_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109058","article-title":"Honokiol alleviates ulcerative colitis by targeting PPAR-gamma-TLR4-NF-kappaB signaling and suppressing gasdermin-D-mediated pyroptosis in vivo and in vitro","volume":"111","author":"Wang","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.xphs.2024.06.010_bib0021","unstructured":"Xiong Y, Weng Y, Zhang H, et al. Preparation and quality evaluation of honokiol nanoparticles using a"},{"issue":"2","key":"10.1016\/j.xphs.2024.06.010_bib0022","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2174\/1567201819666220607153457","article-title":"New polysaccharide polymer as its carrier","volume":"20","year":"2023","journal-title":"Curr Drug Deliv"},{"issue":"1-2","key":"10.1016\/j.xphs.2024.06.010_bib0023","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ijpharm.2009.11.014","article-title":"Preparation of MPEG\u2013PLA nanoparticle for honokiol delivery in vitro","volume":"386","author":"Zheng","year":"2010","journal-title":"Int J Pharm"},{"issue":"4","key":"10.1016\/j.xphs.2024.06.010_bib0024","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/bdd.750","article-title":"Diverse approaches for the enhancement of oral drug bioavailability","volume":"32","author":"Fasinu","year":"2011","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.xphs.2024.06.010_bib0025","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/nrm1244","article-title":"Metchnikoff and the phagocytosis theory","volume":"4","author":"Tauber","year":"2003","journal-title":"Nature Rev Mol. Cell Biol"},{"issue":"2","key":"10.1016\/j.xphs.2024.06.010_bib0026","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/path.2284","article-title":"Macrophage activation by endogenous danger signals","volume":"214","author":"Zhang","year":"2007","journal-title":"J Pathol"},{"issue":"1","key":"10.1016\/j.xphs.2024.06.010_bib0027","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13550-019-0474-0","article-title":"Targeting mannose receptor expression on macrophages in atherosclerotic plaques of apolipoprotein E-knockout mice using (68)Ga-NOTA-anti-MMR nanobody: non-invasive imaging of atherosclerotic plaques","volume":"9","author":"Varasteh","year":"2019","journal-title":"EJNMMI Res"},{"issue":"1","key":"10.1016\/j.xphs.2024.06.010_bib0028","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3109\/03639045.2013.850705","article-title":"Folate-conjugated albumin nanoparticles for rheumatoid arthritis-targeted delivery of etoricoxib","volume":"41","author":"Bilthariya","year":"2015","journal-title":"Drug Dev Ind Pharm"},{"issue":"12","key":"10.1016\/j.xphs.2024.06.010_bib0029","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s00011-020-01398-y","article-title":"Macrophage polarization in intestinal inflammation and gut homeostasis","volume":"69","author":"Moreira Lopes","year":"2020","journal-title":"Inflammat Res"},{"issue":"14","key":"10.1016\/j.xphs.2024.06.010_bib0030","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1016\/j.biomaterials.2013.01.079","article-title":"Galactosylated trimethyl chitosan-cysteine nanoparticles loaded with Map4k4 siRNA for targeting activated macrophages","volume":"34","author":"Zhang","year":"2013","journal-title":"Biomaterials"},{"issue":"11","key":"10.1016\/j.xphs.2024.06.010_bib0031","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1007\/s13204-020-01510-y","article-title":"Fabrication and optimization of pH-sensitive mannose-anchored nano-vehicle as a promising approach for macrophage uptake","volume":"10","author":"Mukhtar","year":"2020","journal-title":"Appl Nanosci"},{"key":"10.1016\/j.xphs.2024.06.010_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2021.112183","article-title":"A holistic QBD approach to design galactose conjugated PLGA polymer and nanoparticles to catch macrophages during intestinal inflammation","volume":"126","author":"Zeeshan","year":"2021","journal-title":"Mater Sci Eng C, Mater Biol Appl"},{"key":"10.1016\/j.xphs.2024.06.010_bib0038","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3389\/fimmu.2017.00669","article-title":"CD169 expressing macrophage, a key subset in mesenteric lymph nodes promotes mucosal inflammation in dextran sulfate sodium-induced colitis","volume":"8","author":"Li","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.xphs.2024.06.010_bib0039","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/978-1-4939-8885-3_13","article-title":"Mouse model of colitis-associated colorectal cancer (CAC): isolation and characterization of mucosal-associated lymphoid cells","volume":"1884","author":"Santiago","year":"2019","journal-title":"Methods Mol Biol (Clifton, NJ)"},{"issue":"3","key":"10.1016\/j.xphs.2024.06.010_bib0040","first-page":"147","article-title":"Soluble P-selectin glycoprotein ligand - a possible new target in ulcerative colitis","volume":"116","author":"Ajdukovic","year":"2015","journal-title":"Bratisl Lek Listy"},{"issue":"1","key":"10.1016\/j.xphs.2024.06.010_bib0041","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.apsb.2017.12.002","article-title":"Biomimetic nanoparticles for inflammation targeting","volume":"8","author":"Jin","year":"2018","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.xphs.2024.06.010_bib0042","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.colsurfb.2018.10.017","article-title":"Mechanical properties of P-selectin PSGL-1 bonds","volume":"173","author":"Farzi","year":"2019","journal-title":"Colloids Surfaces B, Biointerf"},{"issue":"26","key":"10.1016\/j.xphs.2024.06.010_bib0043","doi-asserted-by":"crossref","first-page":"15895","DOI":"10.1073\/pnas.2631433100","article-title":"Leukocyte-inspired biodegradable particles that selectively and avidly adhere to inflamed endothelium in vitro and in vivo","volume":"100","author":"Sakhalkar","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.xphs.2024.06.010_bib0044","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.biomaterials.2004.03.003","article-title":"Characterization of biodegradable drug delivery vehicles with the adhesive properties of leukocytes II: effect of degradation on targeting activity","volume":"26","author":"Eniola","year":"2005","journal-title":"Biomaterials"},{"issue":"10","key":"10.1016\/j.xphs.2024.06.010_bib0045","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/S0142-9612(01)00349-0","article-title":"Characterization of biodegradable drug delivery vehicles with the adhesive properties of leukocytes","volume":"23","author":"Eniola","year":"2002","journal-title":"Biomaterials"},{"issue":"12","key":"10.1016\/j.xphs.2024.06.010_bib0046","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1093\/ibd\/izad099","article-title":"SIRT3 Activator Honokiol Inhibits Th17 Cell Differentiation and Alleviates Colitis","volume":"29","author":"Chen","year":"2023","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.xphs.2024.06.010_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109058","article-title":"Honokiol alleviates ulcerative colitis by targeting PPAR-\u03b3-TLR4-NF-\u03baB signaling and suppressing gasdermin-D-mediated pyroptosis in vivo and in vitro","volume":"111","author":"Wang","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.xphs.2024.06.010_bib0048","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/1755608","article-title":"Honokiol ameliorates DSS-induced mouse colitis by inhibiting inflammation and oxidative stress and improving the intestinal barrier","volume":"2022","author":"Wang","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.xphs.2024.06.010_bib0049","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2147\/IJN.S290444","article-title":"Honokiol\/magnolol-loaded self-assembling lecithin-based mixed polymeric micelles (lbMPMs) for improving solubility to enhance oral bioavailability","volume":"16","author":"Lin","year":"2021","journal-title":"Int J Nanomedicine"},{"issue":"1-2","key":"10.1016\/j.xphs.2024.06.010_bib0050","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijpharm.2011.03.003","article-title":"Improved solubility and pharmacokinetics of PEGylated liposomal honokiol and human plasma protein binding ability of honokiol","volume":"410","author":"Wang","year":"2011","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2024.06.010_bib0051","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2147\/IJN.S214349","article-title":"Development of nanosome-encapsulated honokiol for intravenous therapy against experimental autoimmune encephalomyelitis","volume":"15","author":"Hsiao","year":"2020","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.xphs.2024.06.010_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2021.111778","article-title":"Apigenin-loaded galactose tailored PLGA nanoparticles: a possible strategy for liver targeting to treat hepatocellular carcinoma","volume":"204","author":"Ganguly","year":"2021","journal-title":"Colloids Surfaces B, Biointerfaces"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354924002314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354924002314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T21:56:33Z","timestamp":1725141393000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354924002314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0022354924002314"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2024.06.010","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting Inflammatory Lesions Facilitated by Galactosylation Modified Delivery System Eudragit\/Gal-PLGA@Honokiol for the treatment of Ulcerative Colitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2024.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Pharmacists Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}